{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:14:08Z","timestamp":1761560048765},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41433-019-0596-7","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T11:03:22Z","timestamp":1569409402000},"page":"408-414","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of multiple subconjunctival conbercept injections as an adjuvant to the surgical treatment of pterygium: a prospective randomised comparative 6-month follow-up study"],"prefix":"10.1038","volume":"34","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanxi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donglai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"596_CR1","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.2147\/OPTH.S186543","volume":"12","author":"R Nuzzi","year":"2018","unstructured":"Nuzzi R, Tridico F. How to minimize pterygium recurrence rates: clinical perspectives. Clin Ophthalmol. 2018;12:2347\u20132362. \nhttps:\/\/doi.org\/10.2147\/OPTH.S186543","journal-title":"Clin Ophthalmol"},{"key":"596_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/jop.2015.0109","volume":"32","author":"KY Wu","year":"2016","unstructured":"Wu KY, Lai YH, Yang YC, Wu WC, Hong SJ. 5-Fluorouracil-induced apoptosis changes in cultured corneal epithelial cells. J Ocul Pharm Ther. 2016;32:155\u2013162. \nhttps:\/\/doi.org\/10.1089\/jop.2015.0109","journal-title":"J Ocul Pharm Ther"},{"key":"596_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/039463201202500307","volume":"25","author":"E Bianchi","year":"2012","unstructured":"Bianchi E, Scarinci F, Grande C, Plateroti R, Plateroti P, Plateroti AM, et al. Immunohistochemical profile of VEGF, TGF-\u03b2 and PGE2 in human pterygium and normal conjunctiva: experimental study and review of the literature. Int J Immunopathol Pharm. 2012;25:607\u2013615. \nhttps:\/\/doi.org\/10.1177\/039463201202500307","journal-title":"Int J Immunopathol Pharm"},{"key":"596_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1089\/end.2014.0420","volume":"28","author":"U Uyeturk","year":"2014","unstructured":"Uyeturk U, Gucuk A, Firat T, Kemahli E, Kukner A, Ozyalvacli ME. Effect of mitomycin, Bevacizumab, and 5-fluorouracil to hibit urethral fibrosis in a rabbit model. J Endourol. 2014;28:1363\u20131367. \nhttps:\/\/doi.org\/10.1089\/end.2014.0420","journal-title":"J Endourol"},{"key":"596_CR5","doi-asserted-by":"publisher","first-page":"934963","DOI":"10.1155\/2015\/934963","volume":"2015","author":"L Lytvynchuk","year":"2015","unstructured":"Lytvynchuk L, Sergienko A, Lavrenchuk G, Petrovski G. Antiproliferative, apoptotic, and autophagic activity of ranibizumab, bevacizumab, pegaptanib, and aflibercept on fibroblasts: implication for choroidal neovascularization. J Ophthalmol. 2015;2015:934963 \nhttps:\/\/doi.org\/10.1155\/2015\/934963","journal-title":"J Ophthalmol"},{"key":"596_CR6","doi-asserted-by":"publisher","first-page":"e57642","DOI":"10.1371\/journal.pone.0057642","volume":"8","author":"Z Wu","year":"2013","unstructured":"Wu Z, Zhou P, Li X, Wang H, Luo D, Qiao H, et al. Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modeling. PLoS ONE. 2013;8:e57642 \nhttps:\/\/doi.org\/10.1371\/journal.pone.0057642","journal-title":"PLoS ONE"},{"key":"596_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/eye.2016.29","volume":"30","author":"CO Bekibele","year":"2016","unstructured":"Bekibele CO, Sarimiye TF, Ogundipe A, Olaniyan S. 5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium. Eye(Lond). 2016;30:515\u2013521. \nhttps:\/\/doi.org\/10.1038\/eye.2016.29","journal-title":"Eye(Lond)"},{"key":"596_CR8","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0161-6420(97)30197-3","volume":"104","author":"P Prabhasawat","year":"1997","unstructured":"Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997;104:974\u2013985.","journal-title":"Ophthalmology"},{"key":"596_CR9","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/archopht.1997.01100160405001","volume":"115","author":"DT Tan","year":"1997","unstructured":"Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115:1235\u201340.","journal-title":"Arch Ophthalmol"},{"key":"596_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/ICO.0b013e31818d382d","volume":"28","author":"CC Teng","year":"2009","unstructured":"Teng CC, Patel NN, Jacobson L. Effect of subconjunctival bevacizumab on primary pterygium. Cornea 2009;28:468\u201370. \nhttps:\/\/doi.org\/10.1097\/ICO.0b013e31818d382d","journal-title":"Cornea"},{"key":"596_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/ICO.0000000000001453","volume":"37","author":"G Campagna","year":"2018","unstructured":"Campagna G, Adams M, Wang L, Khandelwal S, Al-Mohtaseb Z. Comparison of pterygium recurrence rates among different races and ethnicities after primary pterygium excision by surgeons in training. Cornea. 2018;37:199\u2013204. 10.1097\/ICO. 0000000000001453","journal-title":"Cornea"},{"key":"596_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08820530902801106","volume":"24","author":"J Mauro","year":"2009","unstructured":"Mauro J, Foster CS. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol. 2009;24:130\u20134. \nhttps:\/\/doi.org\/10.1080\/08820530902801106","journal-title":"Semin Ophthalmol"},{"key":"596_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","volume":"25","author":"AP Adamis","year":"2005","unstructured":"Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005;25:111\u20138.","journal-title":"Retina"},{"key":"596_CR14","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1167\/iovs.13-12141","volume":"54","author":"KW Kim","year":"2013","unstructured":"Kim KW, Park SH, Wee SW, Kim JC. Overexpression of angiogenin in pterygium body fibroblasts and its association with proliferative potency. Invest Ophthalmol Vis Sci. 2013;54:6355\u201362. \nhttps:\/\/doi.org\/10.1167\/iovs.13-12141","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"596_CR15","first-page":"12","volume":"7","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, Lan YQ, Wu GF, Huang QT, Zeng YT. Study on fibroblasts in vasculogenic mimicry of pterygium induced by VEGF. Chin J Ophthalmol Med (Electron Ed). 2017;7:12\u201317. (Chinese)","journal-title":"Chin J Ophthalmol Med (Electron Ed)"},{"key":"596_CR16","first-page":"39","volume":"13","author":"LY Zheng","year":"2016","unstructured":"Zheng LY. Clinical research of the expression of VEGF in recurrent pterygium. Med Innov China. 2016;13:39\u201342. (Chinese)","journal-title":"Med Innov China"},{"key":"596_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/ICO.0b013e3181822615","volume":"28","author":"PC Wu","year":"2009","unstructured":"Wu PC, Kuo HK, Tai MH, Shin SJ. Topical Bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium. Cornea. 2009;28:103\u20134. \nhttps:\/\/doi.org\/10.1097\/ICO.0b013e3181822615","journal-title":"Cornea"},{"key":"596_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10792-015-0076-4","volume":"36","author":"Q Motarjemizadeh","year":"2016","unstructured":"Motarjemizadeh Q, Aidenloo NS, Sepehri S. A comparative study of different concentrations of topical Bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study. Int Ophthalmol. 2016;36:63\u201371. \nhttps:\/\/doi.org\/10.1007\/s10792-015-0076-4","journal-title":"Int Ophthalmol"},{"key":"596_CR19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.18240\/ijo.2018.05.13","volume":"11","author":"TA Mohamed","year":"2018","unstructured":"Mohamed TA, Soliman W, Fathalla AM, Refaie EI. A. Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study. Int J Ophthalmol. 2018;11:797\u2013801. \nhttps:\/\/doi.org\/10.18240\/ijo.2018.05.13","journal-title":"Int J Ophthalmol"},{"key":"596_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/OPTH.S127700","volume":"11","author":"AH Alsmman","year":"2017","unstructured":"Alsmman AH, Radwan G, Abozaid MA, Mohammed UA, Abd Elhaleim NG. Preoperative subconjunctival combined injection of Bevacizumab and mitomycin C before the surgical excision of primary pterygium: clinical and histological results. Clin Ophthalmol. 2017;11:493\u2013501. \nhttps:\/\/doi.org\/10.2147\/OPTH.S127700","journal-title":"Clin Ophthalmol"},{"key":"596_CR21","doi-asserted-by":"publisher","first-page":"6824670","DOI":"10.1155\/2017\/6824670","volume":"2017","author":"R Nuzzi","year":"2017","unstructured":"Nuzzi R, Tridico F. Efficacy of subconjunctival bevacizumab injections before and after surgical excision in preventing pterygium recurrence. J Ophthalmol. 2017;2017:6824670 \nhttps:\/\/doi.org\/10.1155\/2017\/6824670","journal-title":"J Ophthalmol"},{"key":"596_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1874364101610010068","volume":"10","author":"MB Masoumpour","year":"2016","unstructured":"Masoumpour MB, Nowroozzadeh MH, Razeghinejad MR. Current and future techniques in wound healing modulation after glaucoma filtering surgeries. Open Ophthalmol J. 2016;10:68\u201385. \nhttps:\/\/doi.org\/10.2174\/1874364101610010068","journal-title":"Open Ophthalmol J"},{"key":"596_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/ICO.0b013e3182151e0e","volume":"31","author":"K Lekhanont","year":"2012","unstructured":"Lekhanont K, Patarakittam T, Thongphiew P, Suwan-apichon O, Hanutsaha P. Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study. Cornea. 2012;31:155\u201361. \nhttps:\/\/doi.org\/10.1097\/ICO.0b013e3182151e0e","journal-title":"Cornea"},{"key":"596_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10792-013-9852-1","volume":"34","author":"SA Bayar","year":"2014","unstructured":"Bayar SA, Kucukerdonmez C, Oner O, Akova YA. Subconjunctival bevacizumab in the impending recurrent pterygia. Int Ophthalmol. 2014;34:541\u20137. \nhttps:\/\/doi.org\/10.1007\/s10792-013-9852-1","journal-title":"Int Ophthalmol."},{"key":"596_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1089\/jop.2014.0060","volume":"31","author":"A Nava-Castaneda","year":"2015","unstructured":"Nava-Castaneda A, Ulloa-Orozco I, Garnica-Hayashi L, Hernandez-Orgaz J, Jimenez-Martinez MC, Garfias Y. Triple subconjunctival Bevacizumab injection for early corneal recurrent pterygium: one-year follow-up. J Ocul Pharm Ther. 2015;31:106\u2013113. \nhttps:\/\/doi.org\/10.1089\/jop.2014.0060","journal-title":"J Ocul Pharm Ther"},{"key":"596_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/OPTH.S40400","volume":"7","author":"V Hurmeric","year":"2013","unstructured":"Hurmeric V, Vaddavalli P, Galor A, Perez VL, Roman JS, Yoo SH. Single and multiple injections of subconjunctival Ranibizumab for early, recurrent pterygium. Clin Ophthalmol. 2013;7:467\u201373. \nhttps:\/\/doi.org\/10.2147\/OPTH.S40400","journal-title":"Clin Ophthalmol"},{"key":"596_CR27","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00417-013-2392-6","volume":"251","author":"F Wang","year":"2013","unstructured":"Wang F, Bai Y, Yu W, Han N, Huang L, Zhao M, et al. Anti-angiogenic effect of KH902 on retinal neovascularization. Graefes Arch Clin Exp Ohthalmol. 2013;251:2131\u20139. \nhttps:\/\/doi.org\/10.1007\/s00417-013-2392-6","journal-title":"Graefes Arch Clin Exp Ohthalmol"},{"key":"596_CR28","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbrc.2016.01.073","volume":"470","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Tu C, Zhao Y, Liu H, Zhang S. Placental growth factor enhances angiogenesis in human intestinal microvascular endothelial cells via PI3K\/Akt pathway: potential implications of inflammation bowel disease. Biochem Biophys Res Commun. 2016;470:967\u201374. \nhttps:\/\/doi.org\/10.1016\/j.bbrc.2016.01.073","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0596-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:08:26Z","timestamp":1684616906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0596-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0596-7","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}